Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Hypogonadism Clinical Trials

A listing of Hypogonadism medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (13) clinical trials

The primary purpose of this study is to compare the effect of testosterone replacement therapy (TRT) and matching placebo (a gel that is made to look like the TRT but does not have any testosterone drug in it) on major Cardiovascular (CV) events such as heart attack and stroke in ...

Phase

ATTENTION MEN Do you have Low Testosterone and are between the ages of 45-80? If so, you may qualify for this study of topical testosterone replacement therapy in men with low testosterone who are at increased risk for Cardiovascular disease.  

Phase

A study for men with hypogonadal that are increased risk for cardiovascular disease with the use of topical testosterone replacement therapy.  

Phase

Testosterone Therapy in Hypogonadal Men Treated With Opioids

The study duration is 24 weeks. Patients are treated with Testosterone Undecanoate 1000 mg/4 ml, intramuscular (i.m.) or placebo at 0, 6 and 18 weeks. Outcome measures will be evaluated at 0 and 14 weeks.

Phase

Periodontal Profile of Hypogonadic Men

The aim of this study is to assess if hypogonadic men with periodontitis benefit from testosterone replacement therapy before being submitted to periodontal treatment. Fifty hypogonadic men (Total Testosterone <200ng/dL) will be recruited from the Clinics Hospital at Federal University of Paran and subjected to periodontal evaluation by a trained ...

Phase

Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism

Observe safety and efficacy of human menopausal gonadotropin and human chorionic gonadotropin treating congenital hypogonadotropic hypogonadism in teenagers; which as clinic recommendation, may provide clinical basis for establishing standard treatment guideline in the future. Establish technological process and follow-up precept for human menopausal gonadotropin and human chorionic gonadotropin injection treating ...

Phase

TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY

XXY (also known as Klinefelter syndrome) is the most common chromosomal abnormality in males, affecting 1/600 boys. The extra X chromosome leads to insufficient development of the testicles and subsequent testosterone deficiency. Males with XXY also have a high risk for developmental delays, learning disabilities, and cardiovascular disease. An essential ...

Phase

Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)

After the age of 40, there is a gradual decline in the production of testosterone. Among obese men, the decline in testosterone levels is exacerbated by the suppression of the hypothalamic-pituitary-gonadal axis by hyperestrogenemia. The high expression of aromatase enzyme in the adipose tissue enhances the conversion of androgens into ...

Phase

Testosterone for Peripheral Vascular Disease

There is increasing evidence of the linkage of type 2 diabetes with low testosterone levels in men. Testosterone treatment has shown beneficial effects on blood sugar control and obesity in pilot studies in men with type 2 diabetes. Beneficial effects have also been seen on angina- a disease related to ...

Phase